Glioblastoma (GBM) is a very destructive nervous system tumor, and it is almost incurable.
The clinical therapeutic strategies of GBM mainly include surgical resection, combined with …

Glioblastoma (GBM) is the most common primary intracranial malignancy. The
comprehensive treatment mode based on surgical resection has become the key to improve …

The prognosis of malignant gliomas is poor. The 5-year survival rate of patients with
glioblastomas is still less than 10%. It is difficult to cure this disease by a single treatment …

Introduction: Surgical resection used to be the mainstay of treatment for glioma. In the last
decade, however, opinion has changed about the goal of surgical resection in treating …

Glioma, the most prevalent primary malignant tumor of the adult central nervous system, is
highly malignant. Despite the current clinical treatment options including surgical resection …

Glioblastoma (GBM, WHO grade Ⅳ) is the most common and the most malignant primary
brain tumor occurring during adulthood, with an annual incidence of 5 cases per 100 000 …

Glioblastoma (also called glioblastoma multiforme–GBM) is a primary brain neoplasm,
representing about 55% of all gliomas. It is a very aggressive and infiltrative tumor …

OBJECTIVE: To analyze the curative effect and prognostic factors for comprehensive
therapy in patients with high-grade glioma. Methods: Patients with high-grade glioma (WHO …

Objective Glioblastoma is the most common and fatal primary brain tumor in adults. Even
with maximal resection and a series of postoperative adjuvant treatments, the median …

Background Glioblastoma multiforme (GBM) is the most malignant kind of astrocytic tumors
and is associated with a poor prognosis. In this retrospective study, we assessed the clinical …